Related Experiment Video

Updated: Jul 23, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K

[A case report of refractory ALK-positive anaplastic large cell lymphoma treated with Brentuximab vedotin]

Z G Cao1, Z H Wang1, J Z Sun1

  • 1Department of Geriatric Hematology, First Affiliated Hospital of Chinese PLA General Hospital, Beijing 100048, China.

Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|September 21, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.9K

Related Experiment Videos

Last Updated: Jul 23, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.9K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Articles linked to this work by shared authors, journal, and citation graph.

Note: Dynamic strain field mapping with synchrotron X-ray digital image correlation.

The Review of scientific instruments·2014

Rosiglitazone attenuates hyperglycemia-enhanced hemorrhagic transformation after transient focal ischemia in rats.

Neuroscience·2013

Resonance measurement of nonlocal spin torque in a three-terminal magnetic device.

Physical review letters·2012

Lipid-rich carcinoma of the breast: a case report.

Acta chirurgica Belgica·2008

Assessing the genetic relatedness of higher ozone sensitivity of modern wheat to its wild and cultivated progenitors/relatives.

Journal of experimental botany·2008

Pancreatic schwannoma: CT findings.

Abdominal imaging·2005

[Predictive value of dynamic contrast-enhanced magnetic resonance imaging features for the efficacy of neoadjuvant chemotherapy in breast cancer patients with non-mass enhancement].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026

[Efficacy of immunotherapy combined with anti-angiogenesis therapy in patients with advanced NSCLC and identification of prognostic biomarkers].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026

[Comparison of clinical, imaging, pathological and serological characteristics between appendiceal and ovarian mucinous tumors and analysis of causes of misdiagnosis].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026

[Association between functional status-based obesity classification and breast cancer risk: a prospective cohort study].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026

[Drug sensitivity analysis of monotherapy and combination therapy with Chinese and Western drugs in lung cancer organoid models].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026

[Role of DCLK1 overexpression in promoting angiogenesis in colorectal cancer].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026

Bioengineered Stroma-Camouflaged Nanovesicles Disrupt the IDO1/CD276 Immunosuppressive Circuit to Reinvigorate Antitumor Immunity.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

UpTCR: a unified progressive knowledge transfer foundation model for robust T-cell receptor-antigen binding recognition.

Nature communications·2026

Peripheral immune tolerance as a driver of tumor immune escape and therapy resistance.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026

Direct visualization of lysosome-mediated intracellular transport and membrane anchoring of TNF-α in human T cells.

bioRxiv : the preprint server for biology·2026

Blood-brain barrier-traversing multivalent TGFβ trap for anti-cancer immunomodulation of gliomas.

bioRxiv : the preprint server for biology·2026

Predictors of Immediate Therapeutic Lymph Node Dissection Instead of Index Lymph Node After Neoadjuvant Checkpoint Inhibitors: Lessons Learned from the PRADO Trial.

Annals of surgical oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us